Y. Tülüce Et Al. , "Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.," Molecular biology reports , vol.52, no.1, pp.326, 2025
Tülüce, Y. Et Al. 2025. Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.. Molecular biology reports , vol.52, no.1 , 326.
Tülüce, Y., Köstekci, S., Karakuş, F., Keleş, A. Y., & Tunçyürekli, M., (2025). Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.. Molecular biology reports , vol.52, no.1, 326.
Tülüce, Yasin Et Al. "Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.," Molecular biology reports , vol.52, no.1, 326, 2025
Tülüce, Yasin Et Al. "Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.." Molecular biology reports , vol.52, no.1, pp.326, 2025
Tülüce, Y. Et Al. (2025) . "Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.." Molecular biology reports , vol.52, no.1, p.326.
@article{article, author={Yasin Tülüce Et Al. }, title={Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8(+) co-culture model.}, journal={Molecular biology reports}, year=2025, pages={326} }